Home / Government Affairs / Regulatory / Comments

Comments

FDA: A New Era of Smarter Food Safety (December 5, 2019)

Dec 05, 2019
Federal Reserve Board: Settlement of Faster Payments (November 7, 2019)

Nov 07, 2019
DOT FMCSA: Hours of Service (October 21, 2019)

Oct 21, 2019
USDA FNS: Categorical Eligibility for SNAP (September 23, 2019)

Sep 23, 2019
DOT FMCSA: Pilot Program To Allow Drivers Under 21 To Operate Commercial Motor Vehicles in Interstate Commerce (August 13, 2019)

Aug 13, 2019
USDA APHIS: Movement of Certain Genetically Engineered Organisms (August 5, 2019)

Aug 05, 2019
FDA: Products Containing Cannabis or Cannabis-Derived Compounds (July 16, 2019)

Jul 16, 2019
Oral Comments to the 2020-2025 Dietary Guidelines Advisory Committee (July 10, 2019)

Jul 10, 2019
FDA Public Hearing About Products Containing Cannabis or Cannabis-Derived Compounds; Public Comment

May 30, 2019
DOL WHD: Overtime Proposed Rule (May 21, 2019)

May 21, 2019
NLRB: Joint Employer (January 28, 2019)

Jan 28, 2019
CMS: Lower Drug Prices and Reduce Out-of-Pocket Expenses (January 25, 2019)

Jan 25, 2019
DOT FMCSA: Exemption Application for Hours of Service Related to Emergency Preparations (January 17, 2019)

Jan 17, 2019
FDA: Request for Comments - Sesame as an Allergen in Foods (December 31, 2018)

Dec 31, 2018
DHS: Inadmissibility on Public Charge Grounds (December 10, 2018)

Dec 11, 2018
FDA: Draft Guidance on “Retail Consignees to Effectuate Certain Human and Animal Food Recalls” (November 26, 2018)

Nov 26, 2018
FDA: Nutrition Innovation Strategy (October 11, 2018)

Nov 15, 2018
USDA AMS: Proposed Rule: National Bioengineered Food Disclosure Standard (July 3, 2018)

Oct 17, 2018

FMI's comments to USDA AMS on the proposed rule for National Bioengineered Food Disclosure Standard
San Francisco Department of the Environment: Antibiotic Use in Food Animals Ordinance (April 5, 2018)

Apr 05, 2018
FTC: Understanding Competition in U.S. Prescription Drug Markets (December 8, 2017)

Dec 08, 2017

Food Marketing Institute (FMI), on behalf of the food retail industry, seeks to provide input regarding the impact of current intermediaries in the pharmaceutical supply chain on retail pharmacies, and potential solutions to enhance transparency and competition in delivering prescription drugs and medicines to retail pharmacies.

© 2020 FMI. All rights reserved.

2345 Crystal Drive, Suite 800, Arlington, VA 22202 | phone: 202-452-8444 | fax: 202-429-4519

Website design by Matrix Group International, Inc. ®

Sign Up for the

FREE daily briefing on top stories in food retailing.